Literature DB >> 8294447

The immunodominant 38-kDa lipoprotein antigen of Mycobacterium tuberculosis is a phosphate-binding protein.

Z Chang1, A Choudhary, R Lathigra, F A Quiocho.   

Abstract

Several antigens of Mycobacterium tuberculosis have been identified by monoclonal antibodies and are being exploited in the development of improved vaccines and diagnostic reagents, but none has been linked to a specific function. Herein we report that the 38-kDa extracellular lipoprotein antigen, the most potent immunogen of the mycobacteria, is a phosphate-binding protein with features very similar to those of the well characterized periplasmic phosphate-binding protein of Escherichia coli which serves as an initial receptor for active transport. This is also the first report definitively linking a function of a binding protein anchored to a membrane and found in other than Gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294447

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG.

Authors:  P Lefèvre; M Braibant; L de Wit; M Kalai; D Röeper; J Grötzinger; J P Delville; P Peirs; J Ooms; K Huygen; J Content
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

2.  Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis.

Authors:  W Florio; D Bottai; G Batoni; S Esin; M Pardini; G Maisetta; M Campa
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

4.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent.

Authors:  R J Wilkinson; K Hasløv; R Rappuoli; F Giovannoni; P R Narayanan; C R Desai; H M Vordermeier; J Paulsen; G Pasvol; J Ivanyi; M Singh
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis.

Authors:  R J Wilkinson; X Zhu; K A Wilkinson; A Lalvani; J Ivanyi; G Pasvol; H M Vordermeier
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

7.  Detection of pulmonary and extrapulmonary tuberculosis patients with the 38-kilodalton antigen from Mycobacterium tuberculosis in a rapid membrane-based assay.

Authors:  A T Zhou; W L Ma; P Y Zhang; R A Cole
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

8.  Negative electrostatic surface potential of protein sites specific for anionic ligands.

Authors:  P S Ledvina; N Yao; A Choudhary; F A Quiocho
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

9.  The phosphate starvation stimulon of Corynebacterium glutamicum determined by DNA microarray analyses.

Authors:  Takeru Ishige; Malgorzata Krause; Michael Bott; Volker F Wendisch; Hermann Sahm
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

10.  Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease.

Authors:  Akira Hasebe; Atsutoshi Yoshimura; Takeshi Into; Hideo Kataoka; Saori Tanaka; Shinichi Arakawa; Hiroaki Ishikura; Douglas T Golenbock; Tsutomu Sugaya; Nobuo Tsuchida; Masamitsu Kawanami; Yoshitaka Hara; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.